J Korean Med Sci.  2011 Jun;26(6):850-850. 10.3346/jkms.2011.26.6.850.

The Author Response: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis

• Park W

• KMID: 1785978
• DOI: http://doi.org/10.3346/jkms.2011.26.6.850

Abstract

No abstract available.

Reference

1. Marcuzzi A, Crovella S, Pontillo A. Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In Vivo. 2011. 25:87–92.

2. Lim MJ, Kwon SR, Park SG, Park W. Acute effects of intravenous administration of pamidronate in patients with osteoporosis. J Korean Med Sci. 2010. 25:1277–1283.

3. Adami A, Bhalla AK, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V. The acute-phase response after bisphosphonate administration. Calcif Tissue Int. 1987. 41:326–331.

4. Schweitzer DH, Oostendorp-Van de Ruit M, Van der Pluijm G, Löwik CW, Papapoulos SE. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res. 1995. 10:956–962.

5. Sauty A, Pecherstorfer M, Zimmer-Roth I, Fioroni P, Juillerat L, Markert M, Ludwig H, Leuenberger P, Burckhardt P, Thiebaud D. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone. 1996. 18:133–139.

6. Thiébaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int. 1997. 61:386–392.